National service evaluation for paclitaxel HSRs

Dear BOPA members,

We are all very aware of concerns from our members regarding the ongoing supply shortages of ranitidine. Many hospitals will be forced to amend pre-medication regimens to an alternative where there is sparse experience and it is imperative that we collect data that assures us that patient safety is not compromised.

As Co-chair of BOPA, I would like to invite you to take part in a national service evaluation of paclitaxel pre-medication regimes designed by myself in collaboration with Calum Polwart and Pinkie Chambers. Calum has created a bespoke data collection tool (in Excel format) to minimise the administrative burden.

We strongly encourage you to collaborate on this project, so collectively we can gain a better understanding of the impact of changes in practice results from the shortage.

What to do next?

Email me to let us know you are participating ([email protected]). I will send you the data collection tool and an instruction sheet for participants, and we can then keep in touch with you throughout the evaluation period.

Although we have logged the evaluation with the BOPA executive committee and A&R subcommittee, you will still need to register your data collection as a service evaluation at your Trust.

Data collection will take place over a six-month period from 1st July to 31st December (the end date may be amended depending on the amount of data received). We will keep a check on numbers collected and complete an interim analysis as soon as possible. Results of the interim analysis as well as the final results will be presented to participating centres in a timely fashion to assist in clinical decision-making.

If you have any concerns or queries, please contact a member of the team via the email addresses given below.

I will look forward to hearing from you!

Best Wishes

Emma Foreman
Co-chair, British Oncology Pharmacy Association
www.bopa.org.uk

Contacts:
[email protected]
[email protected]
[email protected]
[email protected]

Latest News

By BOPA on 5th August 2022

Don’t miss out, EARLY BIRD RATE until Monday 22nd August 2022

Don’t miss out, EARLY BIRD RATE until Monday 22nd August 2022 Our first in-person meeting in 3 years will be hosted at the world-renowned ACC in Liverpool, set in the…

Read article
By BOPA on 5th August 2022

Community Pharmacist Jackie Lewis – recently featured in the Chemist and Druggist

BOPA’s pioneering Community Pharmacist Jackie Lewis recently featured in the Chemist and Druggist where her work was described critical to the recovery of cancer services post-pandemic.  Jackie is the author…

Read article
By BOPA on 2nd August 2022

Publication update – National SACT regimen specific consent form – Colorectal update

Dear All, The consent form project team is pleased to announce that the colorectal SACT consent forms have been reviewed and updated. They are available on the CRUK website at:…

Read article
By BOPA on 29th July 2022

Message from the BOPA Research Committee

We are delighted to announce that we have received a record-breaking number of abstracts for the 2022 Symposium in Liverpool.  A crack team of markers are now in the process…

Read article

25th BOPA Symposium 2022

7th to 9th October 2022 at The ACC Liverpool

REGISTRATION NOW OPEN!
Members: www.bopa.org.uk/2022-members-symposium-link/
Non members: Contact Media1Productions: [email protected]
Please see Key information before for accommodation information.

DRAFT AGENDA
Please click here to view the latest agenda.

CONFERENCE FEES (includes VAT)
Early-bird rate applies up until Monday 22nd August 2022

Everything you need to know